Genetic or pharmacologic modulation of MUC5B influences the development of pulmonary fibrosis in mice
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with a median survival following diagnosis of two to three years and no known curative therapy. A common gain-of-function variant in the promoter of the lung gel-forming mucin gene MUC5B (rs35705950) is the strongest risk factor for the development of IPF, a finding confirmed by 10 independent studies. Based on this observation, I hypothesize that excess expression of MUC5B damages the distal lung, and when combined with an exogenous insult, results in increased fibroproliferation. This project uses three transgenic ...
(For more, see "View full record.")